The Impact of the Affordable Care Act on Tobacco Cessation Medication Utilization

Newly insured smokers through Medicaid expansion and CA exchanges are a vulnerable group, with a higher prevalence of comorbidities, and unique barriers to utilization of tobacco treatment. Using a sample of smokers who gained access to health care through the Affordable Care Act (ACA) in 2014, the current study will: 1) characterize the demographic and clinical factors that predict use of tobacco cessation medications, and 2) test whether tobacco cessation medication utilization increases from 2014 to 2015, following the elimination of tobacco cessation medication co-payments. Results will inform the improvement of health care services and delivery systems for low income smokers.

<< Back to the list of CRN projects